Study of Perifosine + Capecitabine for Colon Cancer Patients

NCT01048580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Perifosine
DRUG: Capecitabine

Sponsor

AEterna Zentaris

Collaborators

[object Object]